The synthetic pentasaccharide SR 90107A/org 31540 enhances tissue-type plasminogen activator-induced thrombolysis in rabbits
- 31 May 1996
- journal article
- Published by Elsevier in Fibrinolysis
- Vol. 10 (3), 151-157
- https://doi.org/10.1016/s0268-9499(96)80026-9
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial InfarctionNew England Journal of Medicine, 1993
- Nadroparin Calcium1Drugs, 1992
- Adjunctive therapy with low molecular weight heparin with recombinant tissue-type plasminogen activator causes sustained reflow in canine coronary thrombosisAmerican Heart Journal, 1992
- Thrombolysis for pulmonary embolismProgress in Cardiovascular Diseases, 1991
- Intra-arterial thrombolytic therapy in the management of acute and chronic limb ischaemiaBritish Journal of Surgery, 1991
- Role of new antiplatelet agents as adjunctive therapies in thrombolysisThe American Journal of Cardiology, 1991
- Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator in acute myocardial infarctionThe American Journal of Cardiology, 1990
- Enhancement of arterial thrombolysis with native tissue type plasminogen activator by pretreatment with heparin or batroxobin: An angioscopic studyAmerican Heart Journal, 1989
- Intermittent Coronary Occlusion in Acute Myocardial InfarctionNew England Journal of Medicine, 1987
- Thrombolysis with Human Extrinsic (Tissue-Type) Plasminogen Activator in Rabbits with Experimental Jugular Vein Thrombosis. EFFECT OF MOLECULAR FORM AND DOSE OF ACTIVATOR, AGE OF THE THROMBUS, AND ROUTE OF ADMINISTRATIONJCI Insight, 1983